Quickstart guide for the Agilent Seahorse XF Palmitate-BSA FAO Substrate: contents, storage, reagent and media preparation, and running the FAO assay.
This quickstart guide describes the Agilent Seahorse XF Palmitate-BSA FAO Substrate, a bio-available palmitate reagent for researchers studying substrate utilization who need a reliable source of conjugated fatty acids. It lists the kit contents, storage conditions and reagent preparation steps, and gives the recommended volumes of substrate or BSA control for XFe24/XF24 and XFe96/XF96 microplates.
The guide then explains how the XF FAO Assay uses the substrate together with etomoxir and the XF Cell Mito Stress Test to show whether a change in oxygen consumption rate comes from exogenous fatty acids, endogenous fatty acids or uncoupling. It provides substrate-limited medium and FAO assay buffer formulations, a step-by-step assay workflow with recommended volumes and injection concentrations, example kinetic and bar chart data, references, and the product use, warranty and disclaimer statements.
| Palmitate to BSA ratio | 6:1 |
|---|---|
| Substrate contents | 1 mM palmitate conjugated to 0.17 mM BSA in 150 mM NaCl, pH 7.2, 3 × 2 mL vials |
| Control contents | 0.17 mM BSA control in 150 mM NaCl, pH 7.2, 3 × 2 mL vials |
| Storage temperature | -20 °C |
| Shelf life when properly stored | minimum 6 months |
| Kit part number | 102720-100 |
| Recommended volume, XFe24/XF24 | 87.5 µL |
| Recommended volume, XFe96/XF96 | 30 µL |
| Etomoxir final concentration | 40 µM |
| FAO assay buffer NaCl | 111 mM (1x), 555 mM (5x) |
Store it at -20 °C upon arrival; aliquoting and refreezing is optional, and glass vials are recommended for storage. Do not store it in a frost-free freezer.
Three 2 mL vials of 1 mM palmitate conjugated to 0.17 mM BSA in 150 mM NaCl, pH 7.2, and three 2 mL vials of 0.17 mM BSA control in 150 mM NaCl, pH 7.2.
Add 87.5 µL for XFe24/XF24 and 30 µL for XFe96/XF96. Adding the substrate directly to the microplate is recommended instead of using the injection ports.
Selected groups are treated with etomoxir 15 minutes before the XF assay is initiated, and Palmitate:BSA or BSA control is added at t = 0 minutes.